Suzanne Richter

610 University Avenue, M5G 2M9
Toronto, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.

Predictors of cisplatin-induced ototoxicity and survival in chemoradiation treated head and neck cancer patients.

Journal: Oral oncology

Published: September 23, 2018

Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.

Feasibility of Targeting PIK3CA Mutations in Head and Neck Squamous Cell Carcinoma.

Journal: Pathology oncology research : POR

Published: March 03, 2015

Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib.

Evaluation of second-line and subsequent targeted therapies in metastatic renal cell cancer (mRCC) patients treated with first-line cediranib.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: January 02, 2015

Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective.

Practice patterns and perceptions of survivorship care in Canadian genitourinary oncology: A multidisciplinary perspective.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: January 02, 2015

Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

Management of carcinoma of the penis: Consensus statement from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: January 30, 2014

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO).

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: May 15, 2013

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).

A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).

Journal: Investigational new drugs

Published: March 10, 2013

New directions for biologic targets in urothelial carcinoma.

New directions for biologic targets in urothelial carcinoma.

Journal: Molecular cancer therapeutics

Published: May 11, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026